NASH model-- role of interleukin-1 receptor

Medicine and Dentistry

• Receptor Antagonist 100%
• Nonalcoholic Fatty Liver 100%
• Fibrosis 66%
• Atherogenic Diet 66%
• Serositis 33%
• Cytokine 33%
• Histology 33%
• Inflammatory Cell 33%
• Antiinflammatory Activity 33%
• Steatosis 33%
• Interleukin 1 Receptor Blocking Agent 33%
• Interleukin 1 Receptor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor Antagonist 100%
• Nonalcoholic Fatty Liver 100%
• Fibrosis 66%
• Mouse 66%
• Wild Type Mouse 33%
• Cytokine 33%
• Steatosis 33%
• Interleukin 1 Receptor Blocking Agent 33%
• Interleukin 1 Receptor 33%

Immunology and Microbiology

• Steatohepatitis 100%
• Mouse 66%
• Wild Type Mouse 33%
• Inflammatory Cell 33%
• Antiinflammatory Activity 33%
• Interleukin-1 Receptor 33%
• Interleukin 1 Receptor Antagonist 33%
• Inflammation 33%